HomeInsightsPE

Tatva Chintan Pharma Chem Ltd PE Ratio

Tatva Chintan Pharma Chem Ltd PE Ratio

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

2.0 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Tatva Chintan Pharma Chem Ltd

NSE: TATVA

PE

109.3

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of Tatva Chintan Pharma Chem Ltd is 109.3 as of 23 Nov 9.00 AM .
  • The P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 83.2 on March 2024 . This represents a CAGR of 15.93% over 3 years.
  • The Latest Trading Price of Tatva Chintan Pharma Chem Ltd is ₹ 823 as of 22 Nov 15:30 .
  • The PE Ratio of Chemicals Industry has changed from 18.4 to 26.4 in 5 years. This represents a CAGR of 7.49%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Chemicals industry is 51.6. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Tatva Chintan Pharma Chem Ltd

No data available

Company Fundamentals for Tatva Chintan Pharma Chem Ltd

No data available

Image

Tatva Chintan Pharma Chem Ltd

NSE: TATVA

Share Price

₹ 823

15.75 (1.95%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Tatva Chintan Pharma Chem Ltd

1M

1Y

3Y

5Y

Monitoring Tatva Chintan Pharma Chem Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024823
21 Nov 2024807.25
19 Nov 2024829.65
18 Nov 2024829.4
14 Nov 2024832.75
13 Nov 2024840.45
12 Nov 2024881.5
11 Nov 2024876.4
08 Nov 2024905.35
07 Nov 2024908.3

SWOT Analysis Of Tatva Chintan Pharma Chem Ltd

Strength

3

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Tatva Chintan Pharma Chem Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Tatva Chintan Pharma Chem Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Tatva Chintan Pharma Chem Ltd1091,925
Pidilite Industries Ltd761,50,478
SRF Ltd5664,201
Linde India Ltd12455,503
Gujarat Fluorochemicals Ltd10241,885
Deepak Nitrite Ltd4536,422

Key Valuation Metric of Tatva Chintan Pharma Chem Ltd

No data available

No data available

PE Ratio of Chemicals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Tatva Chintan Pharma Chem Ltd

No data available

* All values are in crore

Historical Revenue of Tatva Chintan Pharma Chem Ltd

No data available

* All values are in crore

Historical EBITDA of Tatva Chintan Pharma Chem Ltd

No data available

* All values are in crore

Historical Net Profit of Tatva Chintan Pharma Chem Ltd

No data available

* All values are in crore

Historical Dividend Payout of Tatva Chintan Pharma Chem Ltd

No data available

* All values are in %

About Tatva Chintan Pharma Chem Ltd

  • Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
  • The status of the Company converted from Private Limited into a Public Limited Company effective from 27 January 2021 and the name of Company also changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
  • The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
  • The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), , Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

Tatva Chintan Pharma Chem Ltd News Hub

News

Tatva Chintan Pharma Chem AGM scheduled

Tatva Chintan Pharma Chem announced that the Annual General Meeting (AGM) of the company w...

Read more

2024-08-28 00:00:00

News

Tatva Chintan Pharma Chem to discuss results

Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on ...

Read more

2024-10-17 00:00:00

News

Tatva Chintan Pharma Chem reports consolidated net loss of Rs 0.66 crore in the September 2024 quarter

Net loss of Tatva Chintan Pharma Chem reported to Rs 0.66 crore in the quarter ended Septe...

Read more

2024-10-25 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Tatva Chintan Pharma Chem Ltd

What is the current PE Ratio of Tatva Chintan Pharma Chem Ltd?

The Current PE Ratio of Tatva Chintan Pharma Chem Ltd is 109.3 as on 23 Nov 2024.

What is the average PE Ratio of the Chemicals industry?

The average industry PE Ratio of Chemicals is 51.6 as on 23 Nov 2024.

What was the PE Ratio of Tatva Chintan Pharma Chem Ltd last year?

The PE Ratio of Tatva Chintan Pharma Chem Ltd was 81.23 last year, now the PE ratio is 109.3, showing a year-on-year growth of 34.6%.

What does the PE Ratio of Tatva Chintan Pharma Chem Ltd indicate about its stock?

The PE Ratio of Tatva Chintan Pharma Chem Ltd is 109.3. This ratio indicates that investors are willing to pay 109.3 times the earnings per share for each share of Tatva Chintan Pharma Chem Ltd.

What is the PE Ratio Growth of Tatva Chintan Pharma Chem Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Tatva Chintan Pharma Chem Ltd grew by 34.6% whereas, the EPS ratio grew by -113.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*